Synapse - Works

Results (936)

Randomized phase 2 clinical trial of olaratumab in combination with gemcitabine and docetaxel in advanced soft tissue sarcomas

Journal Article

Attia, S.; Villalobos, V.; Hindi, N.; Wagner, A. J.; Chmielowski, B.; Oakley, G. J. 3rd; Peterson, P. M.; Ceccarelli, M.; Jones, R. L.; Dickson, M. A.
Cancers (2023)

Fulltext@MSK | Save

Interim results of a phase II trial of regional melphalan via limb infusion and systemic PD1 blockade in patients with extremity sarcoma

Meeting Abstract

Bartlett, E. K.; D'Angelo, S.; Kelly, C.; Rosenbaum, E.; Movva, S.; Erinjeri, J.; Fisher, C.; Singer, S.; Antonescu, C.; Ariyan, C.
Annals of Surgical Oncology (2023)

Fulltext@MSK | Save

GOunder/Desmoid Tumor Research Foundation DEsmoid Symptom/Impact Scale (GODDESS©): Psychometric properties and clinically meaningful thresholds as assessed in the phase 3 DeFi randomized controlled clinical trial

Journal Article

Gounder, M. M.; Atkinson, T. M.; Bell, T.; Daskalopoulou, C.; Griffiths, P.; Martindale, M.; Smith, L. M.; Lim, A.
Quality of Life Research (2023)

Fulltext@MSK | Save

An interpretable AI model for recurrence prediction after surgery in gastrointestinal stromal tumour: An observational cohort study

Journal Article

Bertsimas, D.; Margonis, G. A.; Tang, S.; Koulouras, A.; Antonescu, C. R.; Brennan, M. F.; Martin-Broto, J.; Rutkowski, P.; Stasinos, G.; Wang, J.; more...
eClinicalMedicine (2023)

Fulltext@MSK | Save

Results of an open-label, phase Ia/b study of pembrolizumab plus olaratumab in patients with unresectable, locally advanced, or metastatic soft-tissue sarcoma

Journal Article

Sch€offski, P.; Bahleda, R.; Wagner, A. J.; Burgess, M. A.; Junker, N.; Chisamore, M.; Peterson, P.; Szpurka, A. M.; Ceccarelli, M.; Tap, W. D.
Clinical Cancer Research (2023)

Fulltext@MSK | Save

SARC041: A phase 3 randomized double-blind study of abemaciclib versus placebo in patients with advanced dedifferentiated liposarcoma

Meeting Abstract

Dickson, M. A.; Ballman, K. V.; Weiss, M. C.; Attia, S.; Wagner, M. J.; Pollack, S.; Choy, E.; Wagner, A. J.; Wilky, B. A.; Davis, L. E.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Phase 1 dose-expansion study of oral TP-1287, a cyclin-dependent kinase 9 (CDK9) inhibitor, in patients with Ewing sarcoma (EWS)

Meeting Abstract

Cote, G. M.; Wagner, A. J.; Charlson, J. A.; Hu, J. S.; Dickson, M. A.; D'Amato, G. Z.; Kabir, S.; Xu, B.; Lebedinsky, C.; von Mehren, M.
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma

Meeting Abstract

D'Angelo, S. P.; Rosenbaum, E.; Gularte Mérida, R.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

ENVASARC: A pivotal trial of envafolimab and envafolimab in combination with ipilimumab in patients with advanced or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma who have progressed on prior chemotherapy

Meeting Abstract

Riedel, R. F.; Chawla, S. P.; Druta, M.; Jones, R. L.s; Schuetze, S.; Lam, J.; Zhuang, D.; Freddo, J. L.; Adams, B. J.; Theuer, C. P.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

INSIGHT: A phase 3, randomized, multicenter, open-label study of ripretinib vs sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib harboring KIT exon 11 + 17 and/or 18 mutations

Meeting Abstract

George, S.; Blay, J. Y.; Chi, P.; Jones, R. L.; Serrano, C.; Somaiah, N.; Reichmann, W.; Sprott, K.; Achour, H.; Sherman, M. L.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save